Biotechnology
Healthcare
Medical

GlaxoSmithKline

$40.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-0.34%) Today
-$0.18 (-0.44%) After Hours

Why Robinhood?

You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!

About

GlaxoSmithKline plc, also called GlaxoSmithKline, is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. Read More The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees
98,462
Headquarters
Brentford, Greater London
Founded
1999
Market Cap
100.01B
Price-Earnings Ratio
20.84
Dividend Yield
5.40
Average Volume
2.89M
High Today
$40.67
Low Today
$40.30
Open Price
$40.61
Volume
551.01K
52 Week High
$42.36
52 Week Low
$36.13

Collections

Biotechnology
Healthcare
Medical
Pharmaceutical
Female CEOs
Health
Research And Development
Health And Wellness

News

Yahoo FinanceMar 13

Worried about the State Pension? I think the GSK share price could help you retire early

The rising State Pension age is likely to be a continuing concern for people of all ages, as it’s due to increase to 68 over the next two decades.

295
ReutersMar 13

PRESS DIGEST- British Business - March 13

March 13 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - G4S Plc said on Tuesday it received bid interest in its cash-handling business, with contact coming from both private equity firms and rival companies. bit.ly/2XQkXAC - The Early Learning Centre toy business has been sold by Mothercare Plc to The Entertainer group as part of a restructuring of the struggling maternity...

13
Yahoo FinanceMar 12

GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should Know

GlaxoSmithKline (GSK) closed at $40.03 in the latest trading session, marking a -0.12% move from the prior day. GlaxoSmithKline (GSK) closed the most recent trading day at $40.03, moving -0.12% from the previous trading session. This change lagged the S&P 500's 0.3% gain on the day. At the same time, the Dow lost 0.38%, and the tech-heavy Nasdaq gained 0.44%. Coming into today, shares of the drug developer had lost 0.37% in the past month. In that same time, the Medical sector gained 2.07%, while the S&P ...

65

Earnings

$0.34
$0.52
$0.70
$0.88
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available May 1
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.